Promising New PD Fluid

In a Phase 2 study, PD-protec® from Zytoprotec in Vienna, Austria, reduced the risk of peritonitis and of membrane failure. The new fluid was well-tolerated, with no adverse events. Once on the market, this fluid could improve PD outcomes and allow more people to stay longer on the therapy.

Read the full article » | Posted 07-14-2017

Related Articles

• New, 2-lb. WAK 3.0 Receives Patent Posted 03-09-2021
• KidneyX Winners Claim Backpack Kidney Is 18 Months Away Posted 02-09-2021
• The Top 10 Catheter Innovations of 2020 Posted 01-12-2021
• Researchers Use Technology To Print Miniature Human Kidneys In Lab Posted 12-10-2020